[1] 黄飞华,孔繁智,朱婉萍,等.不同相对分子质量壳聚糖乳酸盐体外抑菌实验研究[J].中国海洋药物,2009,28(2):36-39.
[2] 李玉文,张梁栋.甲壳素及其衍生物在医药领域的应用[J].潍坊学院学报,2011, 11(4):80-84.
[3] Pillai CKS,Paul W,Sharma CP.Chitin and chitosan polymers: chemistry, solubility and fiber formation.Prog Polym Sci. 2009; 34(7):641-678.
[4] Cheba BA.Chitin and chitosan:marine biopolymers with unique properties and versatile applications.Global J Biotech Bio-Chem.2011;(3):149-153.
[5] 马群,刘万顺,韩宝芹,等.角膜组织工程支架壳聚糖基共混膜 的制备及性能评价[J].功能材料,2010,41(9):1547-1551.
[6] Liang Y, Liu W, Han B,et al.Fabrication and characters of a corneal endothelial cells scaffold based on chitasan.J Mater Sci: Mater Med.2011;22(1):175-183.
[7] Keogh MB,O' Brien FJ,Daly JS.A novel collagen scaffold supports human osteogenesis--applications for bone tissue engineering.Cell Tissue Res.2010;340(1):169-177.
[8] 王家鸣,任力,龙玉宇,等.壳聚糖-胶原复合膜渗透性能的研究[J].功能材料,2012,43(20):2747-2750.
[9] Wang L,Stegemann JP.Thermogelling chitosan and collagen composite hydrogels initiated with beta-glycerophosphate for bone tissue engineering. Biomaterials. 2010;31(14): 3976- 3985.
[10] 马群,刘万顺,韩宝芹,等.角膜组织工程支架壳聚糖基共混膜的制备及性能评价[J].功能材料,2010,41(9):1547-1551.
[11] Venugopal J,Prabhakaran MP,Zhang Y,et al.Biomimetic hydroxyapatite-containing composite nanofibrous substrates for bone tissue engineering.Philos Trans A Math Phys Eng Sci. 2010;368(1917):2065-2081.
[12] Melton JT,Wilson AJ,Chapman-Sheath P,et al.TruFit CB bone plug: chondral repair, scaffold design, surgical technique and early experiences.Expert Rev Med Devices. 2010; 7(3): 333- 341.
[13] 龙玉宇,任力,王家鸣,等.角膜修复用改性明胶交联膜的生物相容性评价[J].生物医学工程学杂志,2013,20(1):170-175.
[14] Badawi AA,El-Laithy HM,El Qidra RK,et al.Chitosan based nanocarriers for indomethacin ocular delivery.Arch Pharm Res.2008;31(8):1040-1049.
[15] Shah A,Brugnano J,Sun S,et al.The development of a tissue-engineered cornea: biomaterials and culture methods. Pediatr Res.2008;63(5):535-544.
[16] 王雪,颜华.组织工程角膜上皮支架材料研究进展[J].眼科研究, 2010,28(10):998-1002.
[17] Bu P, Vin AP, Sethupathi P,et al. Effects of activated omental cells on rat limbal corneal alkali injury.Exp Eye Res. 2014;121: 143-146.
[18] Murphy CM, O'Brien FJ.Understanding the effect of mean pore size on cell activity in collagen-glycosaminoglycan scaffolds.Cell Adh Migr.2010;4(3):377-381.
[19] 侯江平,李国星,李玉莉,等.角膜内不同部位植入壳聚糖-胶原复合膜的生物相容性[J]. 中国组织工程研究与临床康复, 2010, 14(34):6319-6322.
[20] Hongyok T,Chae JJ,Shin YJ,et al.Effect of chitosan-N- acetylcysteine conjugate in a mouse model of botulinum toxin B-induced dry eye.Arch Ophthal mol. 2009;127(4):525-532.
[21] 郭丽,王迎军,任力,等.明胶固定化壳聚糖膜的细胞相容性评价[J].功能材料,2009,40(9):1525-1528.
[22] Qu C,Xiong Y,Mahmood A,et al.Treatment of traumatic brain injury in mice with bone marrow stromal cell-impregnated collagen scaffolds.J Neurosurg.2009;111(4):658-665.
[23] Notara M,Hernandez D,Mason C,et al.Characterization of the phenotype and functionality of corneal epithelial cells derived from mouse embryonic stem cells.Regen Med. 2012; 7(2): 167-178.
[24] Hu K,Shi H,Zhu J,et al.Compressed collagen gel as the scaffold for skin engineering.Biomed Microdevices. 2010; 12(4): 627-635.
[25] 周晓伟,李国星,朱显丰,等.壳聚糖胶原复合膜在兔角膜基质层间的组织相容性[J].眼视光学杂志,2009,11(6):419-426.
[26] Wang F,Li Y,Shen Y,et al.The functions and applications of RGD in tumor therapy and tissue engineering.Int J Mol Sci. 2013;14(7):13447-13462.
[27] 李娜,周伟,孙恒.人工角膜的研究进展[J].医学综述, 2009,15(4): 575-579. |